HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Myoadenylate deaminase deficiency: successful symptomatic therapy by high dose oral administration of ribose.

Abstract
A 55 years old patient suffering from exercise-induced muscle pain and stiffness due to primary myoadenylate deaminase deficiency has been successfully treated with D-ribose since 1984: single doses of 4 grams administered at the beginning of exercise prevented the symptoms completely; on continuation of exercise this dose had to be repeated all 10-30 min. Total doses of 50-60 g per day were tolerated without side-effects.
AuthorsN Zöllner, S Reiter, M Gross, D Pongratz, C D Reimers, K Gerbitz, I Paetzke, T Deufel, G Hübner
JournalKlinische Wochenschrift (Klin Wochenschr) Vol. 64 Issue 24 Pg. 1281-90 (Dec 15 1986) ISSN: 0023-2173 [Print] Germany
PMID3102830 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Hypoxanthines
  • Lactates
  • Hypoxanthine
  • Lactic Acid
  • Inosine
  • Ribose
  • Ammonia
  • Nucleotide Deaminases
  • AMP Deaminase
  • Xylitol
Topics
  • AMP Deaminase (deficiency)
  • Ammonia (blood)
  • Drug Therapy, Combination
  • Humans
  • Hypoxanthine
  • Hypoxanthines (blood)
  • Inosine (blood)
  • Lactates (blood)
  • Lactic Acid
  • Male
  • Middle Aged
  • Muscles (enzymology)
  • Neuromuscular Diseases (drug therapy, enzymology)
  • Nucleotide Deaminases (deficiency)
  • Physical Exertion
  • Ribose (therapeutic use)
  • Xylitol (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: